Maplight Therapeutics, Inc.

MPLTCIK 0001770069 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 26, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:No prior 10-KFull-doc fallback

Full filing:tone -0.0171

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 14, 2026no items parsed Apr 29, 2026no items parsed Mar 26, 2026no items parsed Jan 9, 2026no items parsed Dec 4, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Maplight Therapeutics, Inc.

Name	Roles	Filings
Kroeger Christopher A.	OfficerDirector	7
Malenka Robert C.	Director	7
Foff Erin Pennock	Officer	6
Hanson Kristopher	Officer	6
Lillie James Woodruff	Officer	6

Showing 1-5 of 13

Per pagePage 1 of 3Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Maplight Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Pavlov George	3	100%	+58.5%	+56.4%	+63.8%	+55.2%
2	Malenka Robert C.	13	0%	-65.3%	-63.5%	-59.6%	-80.2%

All filings

53 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 17, 2026	Hanson Kristopher General Counsel	SSale	1,529	$26.80	$40,977
Apr 17, 2026	Malenka Robert C. Director	SSale	8,593	$26.90	$231,152
Apr 17, 2026	Foff Erin Pennock Chief Medical Officer	SSale	2,044	$26.84	$54,861
Apr 17, 2026	Kreitzer Anatol Chief Discovery Officer	SSale	3,316	$26.61	$88,239
Apr 17, 2026	Setia Vishwas Chief Financial Officer	SSale	2,806	$26.87	$75,397

Showing 16-20 of 53

Per pagePrevPage 4 of 11Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value